Creo Medical Group PLC (LON:CREO – Get Free Report) shares reached a new 52-week low during trading on Friday . The stock traded as low as GBX 27.68 ($0.37) and last traded at GBX 28.34 ($0.37), with a volume of 1053137 shares changing hands. The stock had previously closed at GBX 31.25 ($0.41).
Creo Medical Group Trading Down 9.3 %
The company has a fifty day simple moving average of GBX 29.95 and a two-hundred day simple moving average of GBX 33.39. The company has a quick ratio of 2.19, a current ratio of 3.83 and a debt-to-equity ratio of 13.88. The stock has a market capitalization of £102.53 million, a P/E ratio of -421.43 and a beta of 0.86.
About Creo Medical Group
Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope.
Featured Articles
- Five stocks we like better than Creo Medical Group
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Analysts Predict 85% Upside for Wave Life Sciences After Rate Cut
- What Are Dividends? Buy the Best Dividend Stocks
- FedEx Stock Dips: Another Reason to Fear Recession Is Near
- Consumer Discretionary Stocks Explained
- The Half-Penny Revolution: Will SEC’s Reform Benefit Investors?
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
